The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frequency of BRCA mutation in biliary tract cancer and its correlation with tumor mutational burden (TMB) and microsatellite instability (MSI).
 
Gilbert Spizzo
No Relationships to Disclose
 
Alberto Puccini
No Relationships to Disclose
 
Joanne Xiu
Employment - Caris Life Sciences
 
Richard M. Goldberg
Consulting or Advisory Role - Merck; Merck KGaA; Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Merck; Merck KGaA
 
Axel Grothey
Honoraria - Aptitude Health; Elsevier
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst)
Research Funding - Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme
 
Anthony Frank Shields
Consulting or Advisory Role - Caris Life Sciences; ImaginAb; TransTarget
Speakers' Bureau - GE Healthcare
Research Funding - Bayer; Boehringer Ingelheim; Caris Life Sciences; Daiichi Sankyo; Eisai; Exelixis; H3 Biomedicine; Halozyme; ImaginAb; Incyte; Inovio Pharmaceuticals; Lexicon; LSK BioPharma; Plexxikon; Taiho Pharmaceutical; Torque; Xencor
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget
 
Sukeshi Patel Arora
No Relationships to Disclose
 
Moh'd M. Khushman
Stock and Other Ownership Interests - AstraZeneca; Guardant Health; Halozyme
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences
Speakers' Bureau - AstraZeneca
 
Mohamed E. Salem
Consulting or Advisory Role - Genentech/Roche; Taiho Pharmaceutical
Speakers' Bureau - Genentech/Roche; Taiho Pharmaceutical
Research Funding - Bayer (Inst); Taiho Pharmaceutical (Inst)
 
Francesca Battaglin
Travel, Accommodations, Expenses - Amgen; Bayer
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Oncoceutics; p53-Therapeutics
Research Funding - Bayer; Loxo; Morphotek; Tarmeta Biosciences
Patents, Royalties, Other Intellectual Property - Patent on TIC10 (ONC201); Patents pending on the use of small molecules to target mutant p53
Other Relationship - Caris Life Sciences
 
Ryuma Tokunaga
No Relationships to Disclose
 
Philip Agop Philip
Honoraria - Amgen; ASLAN Pharmaceuticals; Bayer; Biologics; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Lexi Pharma; Merck; Novartis; Rafael Pharmaceuticals; Sanofi
Consulting or Advisory Role - Celgene; Halozyme; Ipsen; Merck; Merrimack; novartis; Rafael Pharmaceuticals
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Celgene; Ipsen; Merck
Research Funding - Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Genentech (Inst); halozyme (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); QED Therapeutics (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); TYME (Inst); tyme (Inst)
Other Relationship - Halozyme
 
Michael J. Hall
Research Funding - AstraZeneca; Caris Life Sciences; Foundation Medicine; InVitae; Myriad Genetics
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Caris Life Sciences; Foundation Medicine; Myriad Genetics
Other Relationship - Caris Life Sciences; Foundation Medicine; Invitae; Myriad Genetics
 
John Marshall
Employment - Caris Life Sciences
Honoraria - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bayer/Onyx; Celgene; Genentech/Roche; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst)
 
Florian Kocher
No Relationships to Disclose
 
Wolfgang Michael Korn
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - OncoCyte
Consulting or Advisory Role - Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - Exelixis
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Andreas Seeber
No Relationships to Disclose